Up-Regulation of hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma

Although huge progress has been made in therapeutics against hepatocellular carcinoma (HCC) over the decades, the prognosis of this lethal disease remains poor. To find out risk factors for HCC-related outcome and better predict the prognosis, there is an unmet need to identify novel biomarkers of H...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xicheng, Wang, Xining, Li, Wenxin, Zhang, Qi, Chen, Jie, Chen, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842961/
https://www.ncbi.nlm.nih.gov/pubmed/31750237
http://dx.doi.org/10.3389/fonc.2019.01105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842961/
https://www.ncbi.nlm.nih.gov/pubmed/31750237
http://dx.doi.org/10.3389/fonc.2019.01105

Ejemplares similares